Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Angelucci

Showing results (61-70 of 166) with videos related to

Pageof 17
Sort By:
Disease Markers|May 28, 2005
Serum levels of anti-myelin antibodies in relapsing-remitting multiple sclerosis patients during different phases of disease activity and immunomodulatory therapyFrancesco Angelucci, Massimiliano Mirabella, Giovanni Frisullo, et al.
Restorative Neurology and Neuroscience|January 9, 2014
Bihemispheric tDCS enhances language recovery but does not alter BDNF levels in chronic aphasic patientsPaola Marangolo, Valentina Fiori, Francesca Gelfo, et al.
Journal of Alzheimer'S Disease : JAD|March 20, 2025
Associations of KLOTHO-VS heterozygosity and α-Klotho protein with cerebrospinal fluid Alzheimer's disease biomarkersAlzbeta Katonova, Ross Andel, Vanesa Jurasova, et al.
Addiction Biology|May 19, 2010
Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptomsFrancesco Angelucci, Valerio Ricci, Giovanni Martinotti, et al.
Biochimica Et Biophysica Acta|June 3, 2015
Leishmania infantum trypanothione reductase is a promiscuous enzyme carrying an NADPH:O2 oxidoreductase activity shared by glutathione reductaseGabriella Angiulli, Antonella Lantella, Elena Forte, et al.
Journal of Cellular Biochemistry|October 13, 2012
Neuroprotective effects of PrxI over-expression in an in vitro human Alzheimer's disease modelAnnamaria Cimini, Roberta Gentile, Francesco Angelucci, et al.
The International Journal of Neuropsychopharmacology|February 23, 2018
Cerebellar BDNF Promotes Exploration and Seeking for NoveltyDaniela Laricchiuta, Diego Andolina, Francesco Angelucci, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 17, 2007
Chronic amphetamine treatment reduces NGF and BDNF in the rat brainFrancesco Angelucci, Susanne H M Gruber, Aram El Khoury, et al.
Current Protein & Peptide Science|May 31, 2014
Thioredoxin reductase and its inhibitorsFulvio Saccoccia, Francesco Angelucci, Giovanna Boumis, et al.
Frontiers in Behavioral Neuroscience|October 7, 2015
Brain-derived neurotrophic factor serum levels correlate with cognitive performance in Parkinson's disease patients with mild cognitive impairmentAlberto Costa, Antonella Peppe, Giovanni Augusto Carlesimo, et al.
Pageof 17

Showing results (61-70 of 166) with videos related to

Sort By:
Pageof 17
Disease Markers|May 28, 2005
Serum levels of anti-myelin antibodies in relapsing-remitting multiple sclerosis patients during different phases of disease activity and immunomodulatory therapyFrancesco Angelucci, Massimiliano Mirabella, Giovanni Frisullo, et al.
Restorative Neurology and Neuroscience|January 9, 2014
Bihemispheric tDCS enhances language recovery but does not alter BDNF levels in chronic aphasic patientsPaola Marangolo, Valentina Fiori, Francesca Gelfo, et al.
Journal of Alzheimer'S Disease : JAD|March 20, 2025
Associations of KLOTHO-VS heterozygosity and α-Klotho protein with cerebrospinal fluid Alzheimer's disease biomarkersAlzbeta Katonova, Ross Andel, Vanesa Jurasova, et al.
Addiction Biology|May 19, 2010
Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptomsFrancesco Angelucci, Valerio Ricci, Giovanni Martinotti, et al.
Biochimica Et Biophysica Acta|June 3, 2015
Leishmania infantum trypanothione reductase is a promiscuous enzyme carrying an NADPH:O2 oxidoreductase activity shared by glutathione reductaseGabriella Angiulli, Antonella Lantella, Elena Forte, et al.
Journal of Cellular Biochemistry|October 13, 2012
Neuroprotective effects of PrxI over-expression in an in vitro human Alzheimer's disease modelAnnamaria Cimini, Roberta Gentile, Francesco Angelucci, et al.
The International Journal of Neuropsychopharmacology|February 23, 2018
Cerebellar BDNF Promotes Exploration and Seeking for NoveltyDaniela Laricchiuta, Diego Andolina, Francesco Angelucci, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 17, 2007
Chronic amphetamine treatment reduces NGF and BDNF in the rat brainFrancesco Angelucci, Susanne H M Gruber, Aram El Khoury, et al.
Current Protein & Peptide Science|May 31, 2014
Thioredoxin reductase and its inhibitorsFulvio Saccoccia, Francesco Angelucci, Giovanna Boumis, et al.
Frontiers in Behavioral Neuroscience|October 7, 2015
Brain-derived neurotrophic factor serum levels correlate with cognitive performance in Parkinson's disease patients with mild cognitive impairmentAlberto Costa, Antonella Peppe, Giovanni Augusto Carlesimo, et al.
Pageof 17